Reporting Results
|
|
|
P9419 |
|
Class #6 |
|
November 17, 2003 |
Why discuss Results in the
Proposal course?
|
|
|
Components of proposal abstract |
|
Research question |
|
Background |
|
Hypotheses |
|
Methods |
|
Results? |
|
Discussion? |
|
|
|
|
Epidemiologic detective
story
|
|
|
Results=who done it |
|
May also exonerate the innocent |
|
Results answer research question. |
|
Support/falsify hypotheses. |
|
Background/literature review will help
readers appreciate your results |
Dataset issues
|
|
|
Population |
|
Variables |
|
Can the data help to answer your
research question? |
|
Sample size constraints |
|
Exploratory/hypothesis-generating vs.
hypothesis-testing |
|
|
Go back to your literature
review
|
|
|
How do other investigators present
their results? |
|
Weaknesses and strengths |
Statistical methods
|
|
|
What methods can be applied to your
dataset to get those answers? |
|
Credibility of your answers depends on
appropriateness of your methods. |
|
|
|
|
Results I.
|
|
|
|
How did your methods work out? |
|
Not the same as in Methods |
|
Methods describes: |
|
Study design, population, time period |
|
recruitment methods |
|
eligibility criteria |
|
informed consent |
|
follow-up, etc. |
|
Results I describes: |
|
how many study participants you
contacted |
|
how many refused, were ineligible,
could not be reached, etc. |
|
Usually text, but if important, table |
Table 1
|
|
|
|
Demographic characteristics |
|
Age |
|
Sex |
|
Race/ethnicity |
|
Income . . . |
|
Clinical characteristics |
|
Stage of disease |
|
Presence/absence/level of biomarkers |
|
Comorbid conditions . . . |
|
Confounders/effect modifiers |
|
|
The most important question
in epidemiology
|
|
|
Compared to what? |
|
Participants to refusers |
|
Cases to controls |
|
Exposed to unexposed |
|
Subjects recruited/interviewed by one
method to subjects recruited/interviewed by another method |
Table 1. Demographic characteristics of cases
and controls
Results II: Main finding(s)
|
|
|
Measure(s) of effect of the
hypothesized exposure on the hypothesized outcome |
|
Risk/rate ratio, odds ratio, prevalence
ratio |
|
Correlation |
|
Risk/rate difference |
|
Mean difference |
|
Assessment of statistical significance |
|
Statistical tests used |
|
Confidence intervals |
|
P values and P for trend |
|
Identification of confounders/effect
modifiers |
Reporting on covariates
|
|
|
Adjusting |
|
Stratifying |
|
Separate analysis of interaction |
|
Interaction term in multivariable model |
Other important findings
|
|
|
Secondary endpoints/exposures |
|
Subgroup analyses |
|
Analyses done in response to questions
raised by the main findings |
Reporting on adjusted
analyses
|
|
|
OR=3.2 (95% CI 1.5-6.8)* |
|
*Adjusted for age, sex, tobacco use .
. . |
|
|
|
Variable OR 95% CI |
|
Main exposure 3.2 1.5-6.8 |
|
Age >50 0.9 0.8-1.0 |
|
Sex, female
1.1 1.0-1.2 |
|
Tobacco use
1.5 1.2-1.8 |
Reporting on stratified
analyses
|
|
|
OR=3.0 (95% CI 1.5-8.9) among males* |
|
OR=3.5 (95% CI 1.8-9.5) among females* |
|
*Adjusted for age, birthplace, alcohol
intake . . . |
|
Table 3. Odds ratios for main exposure and other
factors among males. |
|
Variable OR 95% CI |
|
Main exposure 3.0 1.5-8.9 |
|
Age >50 0.9 0.8-1.0 |
|
Birthplace |
|
NYC 1.0 (Referent) |
|
USA, not NYC 1.2 0.7-1.8 |
|
Not USA 1.6 1.0-2.5 |
|
|
|
|
Slide 16
Slide 17
Your results may. . .
|
|
|
Confirm your hypotheses – gratifying
but doesn’t mean you are a better epidemiologist than if they |
|
Refute your hypotheses – annoying, but
not a cause for shame or mourning |
|
Be inconclusive – may be embarrassing
unless you knew in front that your dataset had limitations (e.g., small
sample size, narrow range of exposures, etc.) |
|
Surprise you – report surprises as
hypothesis generating . . . |
|
|
Discussion
|
|
|
Interpret results |
|
Limit to results presented |
|
Identify unresolved questions |
|
Recommend ways to address them |